Page last updated: 2024-08-18

2,4-diaminotoluene and Experimental Neoplasms

2,4-diaminotoluene has been researched along with Experimental Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balbi, C; Parodi, S; Russo, P; Santi, L; Vecchio, D1
Cunningham, ML; Hayward, JJ; Shane, BS; Tindall, KR1
Bradley, SG; Brown, RD; Burns, LA; Fuchs, BA; Holsapple, MP; Luster, MI; McCay, JA; Musgrove, DL; Stern, M; White, KL1
Boorman, GA; Dieter, MP; Huff, JE; Jameson, CW; Matthews, HB1

Other Studies

5 other study(ies) available for 2,4-diaminotoluene and Experimental Neoplasms

ArticleYear
[DNA damage after treatment in-vivo with several aromatic amines: 2,4-diaminotoluene, 4-aminobenzene (aniline) and paradimethylaminoazobenzene (butter yellow)].
    Bollettino della Societa italiana di biologia sperimentale, 1981, Jan-30, Volume: 57, Issue:2

    Topics: Aniline Compounds; Animals; DNA; Liver; Liver Neoplasms; Neoplasms, Experimental; p-Dimethylaminoazobenzene; Phenylenediamines; Rats

1981
Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene.
    Carcinogenesis, 1995, Volume: 16, Issue:10

    Topics: Animals; Bacterial Proteins; Bacteriophage lambda; Biotransformation; Carcinogens; Dimethylnitrosamine; DNA; Escherichia coli; Escherichia coli Proteins; Genes, Bacterial; Lac Repressors; Male; Mice; Mice, Inbred Strains; Mice, Transgenic; Microsomes, Liver; Mutagenicity Tests; Mutagens; Neoplasms, Experimental; Phenylenediamines; Rats; Repressor Proteins; Salmonella typhimurium; Virus Integration

1995
Immunotoxicity of 2,4-diaminotoluene in female B6C3F1 mice.
    Drug and chemical toxicology, 1994, Volume: 17, Issue:3

    Topics: Administration, Oral; Animals; Antibody Formation; Antigens; B-Lymphocytes; Body Weight; Carcinogens; Complement C3; Dose-Response Relationship, Drug; Female; Hemocyanins; Hypersensitivity, Delayed; Immune System; Infections; Killer Cells, Natural; Liver; Lung Neoplasms; Lymphocyte Activation; Mice; Neoplasms, Experimental; Organ Size; Phagocytosis; Phenylenediamines; Spleen; T-Lymphocytes

1994
NIOSH Current Intelligence Bulletin 53: toluene diisocyanate (TDI) and toluenediamine (TDA); evidence of carcinogenicity.
    MMWR. Morbidity and mortality weekly report, 1991, Mar-22, Volume: 40, Issue:11

    Topics: Animals; Hazardous Substances; Humans; National Institute for Occupational Safety and Health, U.S.; Neoplasms; Neoplasms, Experimental; Occupational Exposure; Phenylenediamines; Toluene 2,4-Diisocyanate; United States

1991
The carcinogenic activity of commercial grade toluene diisocyanate in rats and mice in relation to the metabolism of the 2,4- and 2,6-TDI isomers.
    Toxicology and industrial health, 1990, Volume: 6, Issue:6

    Topics: Animals; Body Weight; Carcinogens; Dose-Response Relationship, Drug; Female; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Phenylenediamines; Rats; Rats, Inbred Strains; Survival Analysis; Toluene 2,4-Diisocyanate

1990